Tranexamic acid

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Tranexamic acid is a synthetic antifibrinolytic agent that specifically inhibits fibrinolysis without interfering with other proteolytic processes.

Pharmacodynamics (Effect)This section has been translated automatically.

The principle of action consists in blocking the specific lysine binding site on the plasminogen. This prevents the binding to fibrin and interrupts fibrinolysis. Derivatives that differ in their specific activity are paraaminomethylbenzoic acids, tranexanoic acid and epsilon-aminocaproic acid.

PreparationsThis section has been translated automatically.

Cyclocapron®

LiteratureThis section has been translated automatically.

  1. HA Neumann (2014) The coagulation system. ABW-Scientific Publisher GmbH Berlin

Authors

Last updated on: 29.10.2020

Author: Prof. Dr. med. Peter Altmeyer